During mammalian sex determination, SOX9 is translocated into the nuclei of Sertoli cells within the developing XY gonad. The N-terminal nuclear localization signal (NLS) is contained within a SOX consensus calmodulin (CaM) binding region, thereby implicating CaM in nuclear import of SOX9. By fluorescence spectroscopy and glutaraldehyde cross-linking, we show that the SOX9 HMG domain and CaM interact invitro. The formation of a SOX9/CaM binary complex is calcium-dependent and is accompanied by a conformational change in SOX9. A CaM antagonist, calmidazolium chloride (CDZ), was observed to block CaM recognition of SOX9 in-vitro and inhibit both nuclear import and consequent transcriptional activity of SOX9 in treated cells. The significance of the SOX9-CaM interaction was highlighted by analysis of a missense SOX9 mutation, A158T, identified from a XY female with campomelic dysplasia/autosomal sex reversal (CD/SRA). This mutant binds importin β normally despite defective nuclear import. Fluorescence and quenching studies indicate that in the unbound state, the A158T mutant shows a similar conformation to that of the WT SOX9, but in the presence of CaM, the mutant undergoes unusual conformational changes. Furthermore, SOX9-mediated transcriptional activation by cells expressing the A158T mutant is more sensitive to CDZ than cells expressing WT SOX9. These results suggest firstly that CaM is involved in the nuclear transport of SOX9 in a process likely to involve direct interaction and secondly, that CD/SRA can arise, at least in part, from a defect in CaM recognition, ultimately leading to reduced ability of SOX9 to activate transcription of cartilage and testes-forming genes.
Introduction SOX (Sry-related HMG 1 box) proteins are a large family of transcription factors that play critical roles in cell-fate, differentiation and development and show diverse, overlapping expression profiles (1, 2) . SOX proteins activate the transcription of target genes by binding to DNA in a sequence-specific manner through their HMG box and by interacting with specific partner-proteins (1, 2).
SOX9, an early embryonically expressed gene, has a role in binding to and regulating a number of genes in the chondrogenesis pathway (3, 4, 5) and testis formation pathway (6) . The influence of SOX9 upon these pathways is evident where mutations in SOX9 result in the disease campomelic dysplasia/autosomal sex reversal (CD/SRA), a severe bone malformation syndrome in which most XY individuals show male-to-female sex reversal (7, 8) . Unlike frameshift and nonsense mutations which
occur throughout the open reading frame of human SOX9, all known missense point mutations in SOX9 that cause CD have been localized at the HMG box (9) .
During early human and mouse embryogenesis, SOX9 is expressed in the cytoplasm of Sertoli cells in both sexes, but by gestational week 7, at the onset of SRY expression in male embryos, SOX9 moves into the nucleus (10, 11) . Here, SOX9
activates the gene for mullerian inhibitory substance (MIS), which is required for the protein that consists of two highly basic regions separated by 9-12 residues (KRPAATKKAGQAKKKK) (12) . The C-terminal NLS of SOX proteins resembles the NLS of the SV40 large-T antigen, which consists of a short stretch of basic residues (PKKKRK) (13) . The fact that both the N-and C-terminal NLS are highly conserved throughout the whole SOX family suggests that the mechanism of nuclear import of SOX proteins is likely to be conserved.
Nuclear import of NLS-containing proteins occurs in two steps. The first step requires recognition of the NLS-containing protein by the transport receptor and docking to the nuclear pore complex (NPC). The second step is an energy-dependent translocation of the NLS-containing protein through the NPC, which requires GTP (14, 15) . In conventional nuclear import pathways, the transport receptor importin α binds to the NLS in the protein. Docking of the protein to the cytoplasmic side of the NPC requires importin β, which binds to the importin α−NLS-protein complex. Importin β interacts with multiple nuclear pore proteins (known as nucleoporins) at the NPC, which then facilitates translocation of the importin/NLS-containing protein complex through the NPC (14, 15) . Translocation to the nucleoplasmic side of the NPC requires multiple docking and undocking reactions involving importin β and nucleoporins, the guanine 6 located in the HMG box. The N-terminal NLS is also a functional NLS, but this NLS is not recognized by importins α or β (20, 21) .
Other mechanisms of nuclear protein import have been described (14, 15) .
Intracellular calcium plays an important role in protein nuclear import. When cytosolic calcium is depleted from the lumen of the endoplasmic reticulum (by treatment of cells with thapsigargin or ionophores), both signal-mediated and passive diffusion of proteins across the nuclear pore complex is inhibited. Sweitzer and Hanover, using a digotininpermeabilised HeLa cell assay system observed a similar effect on nuclear accumulation of the intrinsically fluorescent algal protein, B-phycoerythrin (to which the NLS of the Simian Virus (SV) 40 large T antigen is linked) (22, 23) . After treatment with thapsigargin, nuclear accumulation of proteins occurred only in the presence of GTP, indicative of a Ran/GTP-dependent nuclear import pathway (22, 23) . However, at high cytosolic calcium levels, nuclear import occurs in the absence of GTP, suggesting an alternative Ran/GTP-independent nuclear import pathway (23) .
One of the major cytosolic Ca 2+ -binding proteins is calmodulin (CaM), an intracellular calcium receptor, which is located in both the nucleus and cytoplasm of cells (24) . CaM antagonists, such as calmidizolium (CDZ), W7 and W12, block GTPindependent nuclear import of the SV40 large-T antigen NLS at elevated cytoplasmic calcium levels in permeabilised HeLa cells (23) . The addition of recombinant CaM and 7 passive diffusion respectively) in a permeabilised assay system suggesting that CaM import is facilitated. However ATP depletion was found to not affect CaM import indicating that it is not an active process (25) . Hence the actual mechanism of CaM nuclear import is not clearly understood but may involve associations with CaM binding proteins.
Studies have shown that CaM interacts directly with the C-terminal domain of p21 Cip1 , an inhibitor of the cyclin-dependent kinase, Cdk4 (26, 27) . This domain of interaction, has a highly basic amphiphilic region, which is characteristic of CaM binding domains, and also contains several putative NLSs (27) . Treatment of normal rat kidney (NRK) cells with the CaM antagonist, W7, resulted in cytoplasmic accumulation of p21 Cip1 (26, 27) , indicating that CaM may be able to mediate nuclear import of proteins that contain classical NLS signals.
The SRY HMG box interacts with CaM in a calcium-dependent manner in-vitro (28) . The interaction of SRY with CaM was mapped to a 25-amino acid sequence, located in helix 1 of the SRY HMG box ( Fig. 1 ) (28) . The residues within this domain consist mainly of hydrophobic and basic amino acids that overlap the bipartite Nterminal NLS region, which along with the SV40-like NLS is required for maximal nuclear import of SRY and SOX9 (29) . This domain is highly conserved in the SOX family at both the amino acid sequence and structural levels forming a basic amphiphilic α-helix (Fig. 1) . In this present study, we report that SOX9 can directly bind Ca 2+ -CaM in
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Experimental Procedures SOX9 HMG protein production and purification. Recombinant SOX9 HMG protein (amino acids 101-184) was expressed and purified from Escherichia coli as described (30) with a modification to the protocol as follows. SOX9 HMG protein was extracted from cell pellets which were washed in phosphate buffered saline, followed by sonication in 100 ml HEDA buffer (50 mM HEPES, pH 7.9; 1 mM EDTA; 1 mM DTT; 50 µM AEBSF). The sample was then brought to a final concentration of 450 mM NaCI and mixed with a 0.1 volume of 50% DEAE-Sephadex equilibrated in HEDA/450 mM NaCI for 10 min at 4°C. Following centrifugation (Sorvall RC5B GS3 rotor; 6000 rpm, 10 min, 4°C) the salt concentration of the supernatant was reduced to < 0.2 M by diluting the sample volume 2.5-fold with HEDA buffer and the supernatant was filtered through a 0.45 µM membrane. The sample was injected onto a 10 ml SP-Sepharose FPLC column pre-equilibrated in HEDA buffer containing 200 mM NaCI. Bound proteins were eluted over 40 min with a salt gradient of HEDA buffer containing 200 mM to 1000 mM NaCI and 5 ml fractions collected. SOX9 HMG protein elutes in fractions at about 0.7 M NaCI. SOX9 HMG protein was desalted and concentrated using Amicon Centricon 3 columns. Protein concentrations were determined using Bradford assay reagent kit (BIORAD) and bovine serum albumin as a standard.
Native polyacrylamide gel electrophoresis. Gel and buffer composition were essentially as for SDS-PAGE in standard Tris-glycine buffers but lacking SDS, and consisting of a 12.5% separating gel and a 5% stacking gel (28 DNA was added, and the mixture was incubated on ice for a further 30 minutes before measurements were taken.
Excitation of tryptophan residues was accomplished using an excitation wavelength of 295 nm from a 450 W Xenon lamp. Emission spectra were measured in the wavelength range of 300 nm to 500 nm, and through a polarizer oriented at the magic angle (54.7 o ). The spectral band pass of excitation and emission was 5 nm.
Spectra were fully corrected for the wavelength response of the detection system. The cell block was maintained at 20°C with a circulating water bath. transcriptional activity, CAT-ELISA assays were performed as described previously (32) . Linear regression (Microsoft Excel) was used to calculate the slope of (transcriptional activation and its projection was used to determine the 50% inhibition constant (IC 50 ) of the drug on transfected cells.
Immunohistochemistry. COS7 cells were transiently transfected with 500 ng pcDNA3-SOX9 using lipofectamine (GIBCO-BRL) according to manufacturer instructions. The antagonists W7, W12, CPA and CDZ at concentrations ranging from 3
µM to 300 µM were added 24 h after transfection and the transfected COS7 cells incubated for a further 24 h prior to protein detection. SOX9 protein was detected as described previously (32) . Similarly, EGTA was added 24 h after transfection, and the transfected cells were incubated for a further 20 min before immunohistochemistry.
Confocal laser scanning microscopy (CLSM) (BIORAD MRC-500) was used for quantitation of nuclear accumulation of SOX9 protein and was performed as described (33) . Measurements were taken of the density of fluorescence from the cytoplasm and the nucleus with the background fluorescence subtracted from the equation: Fn/c = (nbkgdn)/(cp -bkgdncp) where n = nucleus and bkgdn = background in the nucleus, cp = cytoplasm and bkgdncp = background in the cytoplasm.
Results
We showed previously that the SRY HMG box can interact with CaM in a calcium-dependent manner through a 25-amino acid sequence, located in helix 1 of the SRY HMG box which includes the N-terminal NLS ( Fig. 1 ) (28) . This domain is highly conserved among members of the SOX family suggesting that CaM is likely to bind to other SOX proteins ( Fig. 1 ). E.coli recombinant SOX9 HMG box was purified to about 95% homogeneity as observed by Coomassie stained SDS-PAGE gel ( Fig. 2A , Lane 2).
Next, SOX9 HMG box protein was electrophoresed on a native PAGE gel in the presence or absence of CaM, and the calcium dependence of the interaction between SOX9 and CaM was assessed. In this gel system SOX9 HMG box alone is too basic to migrate into the gel ( To determine the stoichiometry of the binding, CaM and radiolabelled SOX9 were incubated with a cross-linking agent. 35 S-Met labelled SOX9 migrates as a single band at about 65 kDa, slightly higher than its predicted molecular weight of 61 kDa ( To further investigate the SOX9-CaM interaction, a CaM antagonist, calmidazolium chloride (CDZ), was used to directly test its effect on SOX9-CaM complex formation on native gels. CDZ is an imidazole compound that binds very strongly to CaM (36, 37) . CDZ varying from 0.3 to 30 µM was incubated with SOX9 and CaM (Fig. 4) . Densitometric analysis of Coomassie blue-stained bands revealed that 0.3
µM CDZ reduced SOX9-CaM complex by about 2-fold and 3 µM CDZ by a further 2.5-fold whereas 30 µM CDZ reduced complex formation by a further 20-fold. Thus the CDZ inhibition of SOX9-CaM complex had the largest effect between 3 and 30µM. We conclude that CDZ can directly inhibit the interaction between SOX9 and CaM in-vitro in a dose-dependent manner.
To study the effects of CaM antagonists on nuclear accumulation of SOX9, COS7 cells were transiently transfected with pcDNA3-SOX9 and treated with 3 µM of CDZ, W7, W12 or CPA. SOX9 protein was detected by indirect immunofluorescence and CLSM (Fig. 5A) . CaM antagonist W7, a naphthalene sulfonamide derivative binds directly to and inhibits CaM at the dosage used in this study (38, 39, 40) . W12 is a compound structurally related to W7 but with much lower affinity for CaM (38, 39, 40, 41) . All three compounds bind to the exposed hydrophobic surface of CaM preventing the binding of Ca 2+ to CaM. This prevents CaM from adopting the conformation required for recognition by CaM-binding proteins. The potency of each antagonist upon nuclear accumulation and the IC 50 value for the inhibition of CaM-stimulated phosphodiesterase activity have been previously described (23, 38, 39, 40, 42) . SOX9 protein is exclusively localised in the nucleus of untreated cells (Fig. 5A, column 1 ). SOX9 cytoplasmic staining could be seen in 3 µM CDZ and W7 (Fig. 5A , column 2) treated cells. In contrast, cells treated with the low affinity CaM binder W12, showed no SOX9 cytoplasmic staining (Fig. 5A, column 2 ). To quantify SOX9 nuclear accumulation in COS7 cells from the immunofluorescence data, CLSM image analysis was performed on SOX9-expressing COS7 cells at each concentration of antagonist (Fig. 5B) . At 3 µM of CDZ, a two-fold reduction of nuclear accumulation of SOX9 was detected when compared to untreated cells (Fig. 5B ). This decrease was significant (p = 0.001). CDZ concentrations of 30 µM and 300 µM did not show any further decreases in nuclear accumulation of SOX9 when compared to 3 µM of CDZ (data not shown). For W7, a significant reduction in SOX9 nuclear accumulation was observed at 3 µM compared to untreated cells, but the extent of reduction was not as dramatic as that observed for CDZ treatment (p = 0.009) (Fig. 5B) . For W12, no significant difference in SOX9 nuclear accumulation was observed compared to untreated cells (Fig. 5B) . Thus the known potency of CaM antagonists correlates with their ability to reduce SOX9-CaM interaction and affects SOX9 nuclear import.
Given the observed calcium dependency of SOX9 interaction with CaM in-vitro Taken together with the effects of the CaM antagonists, the data suggests that calciumbound CaM is required for SOX9 nuclear import.
To investigate the effect of CaM antagonists on SOX9 transcriptional activity, CDZ was added to COS7 cells previously transfected with pcDNA3-SOX9 and the SOX reporter construct pS 10 E1bCAT, which is an adenovirus E1b promoter CAT reporter plasmid containing 10 copies of the SOX consensus element (AACAAT)to confer SOX9 responsiveness to the E1b promoter. The transcription control plasmid, pCMV-lac, was also included as an internal control for basal transcription levels. SOX9 transcriptional activity was then assayed for CAT expression. In the untreated cells, we obtained a ~13-fold activation of the (SCE) 10 -E1b-CAT reporter when compared with E1bCAT basal transcription control reporter (Fig. 6, column 1, row 1 ). The addition of CDZ resulted in a reduction of transcriptional activity in the transfected cells. Transactivation by SOX9 was reduced by 50% in cells treated with 9 µM CDZ when compared to the untreated cells. Consistent CMV promoter-driven β-galactosidase activity throughout all samples in this assay indicate that the decrease in transcription activity was not due to general changes in polymerase II transcription with increasing concentrations of CDZ used.
In addition to WT SOX9, a previously characterized point mutant, A158T, from a XY female with campomelic dysplasia (CD) was investigated (19) . This substitution of a small alanine molecule with a bulky threonine molecule destabilized the hydrophobic core of the HMG domain which is believed to stabilize SOX9 conformation (Fig.1 ). This mutant displayed normal DNA bending properties although its ability to bind DNA was reduced (19) . Immunofluorescence localization of the A158T mutant protein showed a 50% reduction in nuclear accumulation (despite binding to importin-β with the same affinity as that of the WT SOX9 protein), suggesting a defect in an importin-β-independent nuclear import pathway (19) .
Consistent with our previous observations (19), we observed that transcriptional activity of the A158T mutant was significantly lower than that of the WT SOX9 protein when the same amount (13ng) of pcDNA3-SOX9-A158T was transfected into COS7 cells (Fig. 6, column 2, row 1) . Hence, the decreases in transcriptional activity due to the addition of CDZ were barely observable (Fig. 6, column 2, row 1) . In order to compare the sensitivity of the wildtype SOX9 and A158T mutant expressing cells, an increased amount (2-fold) of pcDNA3-SOX9-A158T was used to obtain transcriptional activity at levels comparable with that of the WT protein (Fig. 6, column 3, row 1 ). The A158T mutant showed a steeper drop in transcriptional activity in response to CDZ treatment compared to WT SOX9 (Fig. 6, column 3, row 1) . Linear regression analysis indicated that the transcriptional activity of WT SOX9 was inhibited by 50% at 9.75 µM CDZ. In contrast, only 5.5 µM of CDZ was calculated to give a 50% decrease in the A158T mutant-expressing cells. Hence, transcriptional activation by nuclear import-defective SOX9 mutant A158T was apparently more sensitive to CDZ when compared to WT SOX9, suggesting a CaM defect in this CD/SRA patient.
In order to assess directly CaM binding to the A158T mutant, we compared the fluorescence profiles of WT and mutant HMG domains in the presence and absence of bound CaM (Fig. 7A ). The intensity of tryptophan fluorescence is sensitive to the environment about the indole chromophore and can provide information concerning changes in protein structure and dynamics. SRY fluorescent emission data was also included to enable comparison (28) . Using an excitation wavelength of 295 nm which excites tryptophan residues only, CaM-bound WT SOX9 blue-shifted the emission maximum by 10 nm from the free unbound state to the bound state. A similar value (9 nm) was observed for SRY as previously reported (28) . In the case of the mutant A158T, a blue shift was recorded although the change in emission maximum was only 2 nm -5 fold lower than that of WT SOX9 (Fig. 7A ). This small shift observed in the A158T mutant suggests that A158T has a different structure compared to the WT SOX9 protein when bound to CaM.
In order to investigate further the nature of the microenvironments in the WT SOX9 and mutant HMG domains, acrylamide quenching was used to measure the accessibility of tryptophan residues to a quenching agent. In the absence of CaM as shown previously and confirmed here (18) , similar fluorescence quenching profiles of both the WT and A158T SOX9 mutant indicate no changes in the accessibility to acrylamide (Fig. 7B) suggesting that the tryptophan residues in both proteins are equally accessible to solvent. The effect of the addition of CaM on the tryptophan accessibility to acrylamide is shown in Figure 7C . In the CaM-SOX9 wild-type complex, only a minor change in the tryptophan acrylamide quenching profile was observed while the quenching profile of the mutant A158T SOX9-CaM complex changed significantly compared to the uncomplexed situation. An analysis of the quenching profiles in terms of a two-site (one site accessible, one site inaccessible) model (see Materials and Methods) showed that in the WT SOX9 and A158T SOX9 proteins, all of the tryptophan fluorescence was accessible to quenching. In the WT SOX9 protein, the effect of CaM complexation was to slightly increase (by 5%) the average accessibility of the two tryptophan residues to solvent. However in the A158T SOX9-CaM complex, the analysis suggested that complex formation resulted in complete shielding of about 50% HMG model (32) , the W143 residue located at the end of helix 2 stacks on W115 residue (Fig. 1) . These residues form part of the hydrophobic core, which is predicted to maintain the angles between helices 1 and 2 and helices 2 and 3. Hence, any changes Residual SOX9 nuclear import in the presence of 3 µM CaM antagonist treatment might be attributed to the importin-dependent activity of the C-terminal NLS. Hence, both CaM and importin nuclear import pathways are probably required to give maximal SOX9 nuclear accumulation and may in fact contribute equally (Fig. 8) . This would explain why CaM antagonists were unable to inhibit nuclear import of SOX9 by much more than 50%. Transcriptional activity of SOX9 was reduced to a lesser extent than was nuclear import (Fig 5, 6 ). With CDZ, import was reduced to 50% at 3 µM whereas transcription was reduced to 50% at 9.75 µM. This could be due to SOX9 binding cooperatively to multimerised SOX sites in the CAT reporter used here (data not shown),
analogous to co-operative binding of SOX9 to targets in-vivo such as Col11a2 (45) .
Co-incident with the onset of SRY expression in the developing mouse XY gonad, the subcellular location of SOX9 changes from cytoplasmic to nuclear (11) . This differential onset of expression suggests that a highly specific mechanism acts to 
